CGS 15943 [Ligand Id: 384] activity data from GtoPdb and ChEMBL

Click here for a description of the charts and data table

Please tell us if you are using this feature and what you think!

ChEMBL ligand: CHEMBL16687 (CGS-15943)
  • A1 receptor/Adenosine A1 receptor in Human [ChEMBL: CHEMBL226] [GtoPdb: 18] [UniProtKB: P30542]
  • A1 receptor/Adenosine A1 receptor in Rat [ChEMBL: CHEMBL318] [GtoPdb: 18] [UniProtKB: P25099]
  • Adenosine A1 receptor in Guinea pig [ChEMBL: CHEMBL2304404] [UniProtKB: P47745]
There should be some charts here, you may need to enable JavaScript!
  • A2A receptor/Adenosine A2a receptor in Human [ChEMBL: CHEMBL251] [GtoPdb: 19] [UniProtKB: P29274]
  • A2A receptor/Adenosine A2a receptor in Rat [ChEMBL: CHEMBL302] [GtoPdb: 19] [UniProtKB: P30543]
There should be some charts here, you may need to enable JavaScript!
  • A2B receptor/Adenosine A2b receptor in Human [ChEMBL: CHEMBL255] [GtoPdb: 20] [UniProtKB: P29275]
  • A2B receptor in Mouse [GtoPdb: 20] [UniProtKB: Q60614]
There should be some charts here, you may need to enable JavaScript!
  • A3 receptor/Adenosine A3 receptor in Human [ChEMBL: CHEMBL256] [GtoPdb: 21] [UniProtKB: P0DMS8]
  • A3 receptor/Adenosine A3 receptor in Rat [ChEMBL: CHEMBL3360] [GtoPdb: 21] [UniProtKB: P28647]
There should be some charts here, you may need to enable JavaScript!
  • casein kinase 1 alpha 1/Casein kinase I alpha in Human [ChEMBL: CHEMBL2793] [GtoPdb: 1995] [UniProtKB: P48729]
There should be some charts here, you may need to enable JavaScript!
  • casein kinase 1 delta/Casein kinase I delta in Human [ChEMBL: CHEMBL2828] [GtoPdb: 1997] [UniProtKB: P48730]
There should be some charts here, you may need to enable JavaScript!
  • casein kinase 1 epsilon/Casein kinase I epsilon in Human [ChEMBL: CHEMBL4937] [GtoPdb: 1998] [UniProtKB: P49674]
There should be some charts here, you may need to enable JavaScript!
  • protein kinase, DNA-activated, catalytic subunit/DNA-dependent protein kinase in Human [ChEMBL: CHEMBL3142] [GtoPdb: 2800] [UniProtKB: P78527]
There should be some charts here, you may need to enable JavaScript!
  • phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha/PI3-kinase p110-alpha subunit in Human [ChEMBL: CHEMBL4005] [GtoPdb: 2153] [UniProtKB: P42336]
There should be some charts here, you may need to enable JavaScript!
  • phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta/PI3-kinase p110-beta subunit in Human [ChEMBL: CHEMBL3145] [GtoPdb: 2154] [UniProtKB: P42338]
There should be some charts here, you may need to enable JavaScript!
  • phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta/PI3-kinase p110-delta subunit in Human [ChEMBL: CHEMBL3130] [GtoPdb: 2155] [UniProtKB: O00329]
There should be some charts here, you may need to enable JavaScript!
  • phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma/PI3-kinase p110-gamma subunit in Human [ChEMBL: CHEMBL3267] [GtoPdb: 2156] [UniProtKB: P48736]
There should be some charts here, you may need to enable JavaScript!
There should be some charts here, you may need to enable JavaScript!
DB Assay description Assay Type Standard value Standard parameter Original value Original units Original parameter Reference
A1 receptor/Adenosine A1 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL226] [GtoPdb: 18] [UniProtKB: P30542]
ChEMBL The A1-StaR receptor has been purified from membranes in n-decyl-beta-D-maltoside as detergent. Ligands were prepared over a five-fold concentration series and injected in either a multi- or a single-cycle format depending on the kinetic parameters of the ligand. The actual concentrations as well as contact and dissociation times varied between the ligands depended on the kinetics and affinity of the interaction. The data were fitted to a 1:1 interaction model using the kinetics evaluation software from Biacore. B 7.12 pKd 75.38 nM Kd K4DD drug target binding kinetics data
ChEMBL Binding affinity for human Adenosine A1 receptor from HEK293 cells B 8.35 pKi 4.5 nM Ki J Med Chem (1996) 39: 4142-4148 [PMID:8863790]
ChEMBL Displacement of [3H]DPCPX from human adenosine A1 receptor expressed in CHO cells; range 4.1-4.7 B 8.36 pKi 4.4 nM Ki J Med Chem (2000) 43: 4768-4780 [PMID:11123985]
GtoPdb - - 8.46 pKi 3.5 nM Ki Naunyn Schmiedebergs Arch Pharmacol (1999) 359: 7-10 [PMID:9933143]
A1 receptor/Adenosine A1 receptor in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL318] [GtoPdb: 18] [UniProtKB: P25099]
ChEMBL Tested for the displacement [3H]PIA from Adenosine A1 receptor in rat brain membrane B 4.68 pKi 21000 nM Ki J Med Chem (1996) 39: 398-406 [PMID:8558508]
ChEMBL Binding affinity was determined in radioligand binding assay at rat brain adenosine A1 receptor vs [3H]R-PIA B 7.68 pKi 21 nM Ki J Med Chem (1998) 41: 2835-2845 [PMID:9667972]
ChEMBL Displacement of [3H]DPCPX binding to adenosine A1 receptor of rat brain cortical membrane B 7.68 pKi 21 nM Ki J Med Chem (2001) 44: 749-762 [PMID:11262085]
ChEMBL Inhibition of [3H]CHA binding to Adenosine A1 receptor in rat brain membranes B 7.68 pKi 21 nM Ki J Med Chem (1990) 33: 1708-1713 [PMID:2342066]
ChEMBL Binding affinity against adenosine A1 receptor using [3H]-CHA or [3H]PIA as radioligand B 7.68 pKi 21 nM Ki J Med Chem (1992) 35: 407-422 [PMID:1738138]
ChEMBL Binding affinity towards adenosine A1 receptor in rat whole brain membranes using N6-[3H]cyclohexyladenosine B 7.69 pKi 20.5 nM Ki J Med Chem (1992) 35: 3066-3075 [PMID:1501234]
GtoPdb - - 8.19 pKi 6.4 nM Ki Drugs Future (2000) : 1043-1052
ChEMBL Binding ability of adenosine A1 receptor by using [3H]CHA as radioligand in rat whole brain homogenate B 8.19 pKi 6.4 nM Ki Bioorg Med Chem Lett (1994) 4: 2539-2544
ChEMBL Displacement of [3H]CHA from rat cortical membrane Adenosine A1 receptor. Parenthesis indicate 95% confidence limit. B 8.19 pKi 6.4 nM Ki J Med Chem (1998) 41: 2126-2133 [PMID:9622554]
ChEMBL Inhibition of [3H]-CHA binding to Adenosine A1 receptor in rat whole brain homogenates. B 8.19 pKi 6.4 nM Ki J Med Chem (1996) 39: 1164-1171 [PMID:8676354]
ChEMBL Inhibition of rat recombinant adenosine A1 receptor B 8.46 pKi 3.5 nM Ki J Med Chem (2014) 57: 3623-3650 [PMID:24164628]
ChEMBL Binding affinity for Adenosine A1 receptor from rat cerebral cortex membranes using [3H](R)-PIA B 7.68 pIC50 21 nM IC50 J Med Chem (1996) 39: 4142-4148 [PMID:8863790]
ChEMBL Binding affinity towards the adenosine A1 receptor in cerebral cortices of Sprague-Dawley male rats using [3H]CHA as radioligand. B 8.22 pIC50 6 nM IC50 J Med Chem (1990) 33: 2240-2254 [PMID:2374150]
Adenosine A1 receptor in Guinea pig (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2304404] [UniProtKB: P47745]
ChEMBL Binding affinity against adenosine A1 receptor in guinea pig forebrain membranes using N6-[3H]cyclohexyladenosine as radioligand B 8 pKi 10 nM Ki J Med Chem (1992) 35: 3066-3075 [PMID:1501234]
A2A receptor/Adenosine A2a receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL251] [GtoPdb: 19] [UniProtKB: P29274]
ChEMBL The A2A-StaR2 receptor has been purified from membranes in n-decyl-beta-D-maltoside as detergent. Ligands were prepared over a five-fold concentration series and injected in either a multi- or a single-cycle format depending on the kinetic parameters of the ligand. The actual concentrations as well as contact and dissociation times varied between the ligands depended on the kinetics and affinity of the interaction. The data were fitted to a 1:1 interaction model using the kinetics evaluation software from Biacore. A minimum of three measurements were recorded for each interaction. B 8.49 pKd 3.24 nM Kd K4DD drug target binding kinetics data
ChEMBL Displacement of [3H]ZM241385 from human recombinant adenosine A2A receptor expressed in in human HeLa cell membrane B 8.64 pKi 2.27 nM Ki Bioorg Med Chem (2010) 18: 2081-2088 [PMID:20202853]
ChEMBL Binding affinity for human Adenosine A2A receptor from HEK293 cells B 8.77 pKi 1.7 nM Ki J Med Chem (1996) 39: 4142-4148 [PMID:8863790]
ChEMBL Binding affinity against S277E human adenosine A2A receptor expressed in CHO cells using [3H]- ZM-241385 B 9 pKi 1 nM Ki J Med Chem (2003) 46: 4847-4859 [PMID:14584936]
ChEMBL Binding affinity against T88D human adenosine A2A receptor expressed in CHO cells using [3H]- ZM-241385 B 9.04 pKi 0.91 nM Ki J Med Chem (2003) 46: 4847-4859 [PMID:14584936]
ChEMBL Binding affinity for HA-tagged mutant human Adenosine A2A receptor (V84L), using [3H]CGS-21680 as radioligand expressed in COS-7 cells B 9.07 pKi 0.84 nM Ki J Med Chem (1997) 40: 2588-2595 [PMID:9258366]
ChEMBL Binding affinity against WT human adenosine A2A receptor expressed in CHO cells using [3H]- ZM-241385 B 9.08 pKi 0.84 nM Ki J Med Chem (2003) 46: 4847-4859 [PMID:14584936]
ChEMBL Binding affinity against T88E human adenosine A2A receptor expressed in CHO cells using [3H]- ZM-241385 B 9.17 pKi 0.67 nM Ki J Med Chem (2003) 46: 4847-4859 [PMID:14584936]
ChEMBL Binding affinity against H278E human adenosine A2A receptor expressed in CHO cells using [3H]- ZM-241385 B 9.28 pKi 0.52 nM Ki J Med Chem (2003) 46: 4847-4859 [PMID:14584936]
ChEMBL Binding affinity for HA-tagged mutant human Adenosine A2A receptor (H250N) using [3H]-CGS-21,680 as radioligand expressed in COS-7 cells B 9.34 pKi 0.46 nM Ki J Med Chem (1997) 40: 2588-2595 [PMID:9258366]
ChEMBL Displacement of [3H]-SCH- 58261 from human adenosine A2A receptor expressed in CHO cells; range 0.37-0.49 B 9.37 pKi 0.43 nM Ki J Med Chem (2000) 43: 4768-4780 [PMID:11123985]
ChEMBL Binding affinity against H278D human adenosine A2A receptor stably transfected in CHO cells using [3H]- ZM-241385 as radioligand. B 9.39 pKi 0.41 nM Ki J Med Chem (2003) 46: 4847-4859 [PMID:14584936]
ChEMBL Binding affinity to human adenosine A2A receptor B 9.4 pKi 0.4 nM Ki J Med Chem (2008) 51: 4449-4455 [PMID:18637670]
GtoPdb - - 9.4 pKi - - - Naunyn Schmiedebergs Arch Pharmacol (1998) 357: 1-9 [PMID:9459566];
Naunyn Schmiedebergs Arch Pharmacol (1999) 359: 7-10 [PMID:9933143];
J Biol Chem (1995) 270: 13987-97 [PMID:7775460];
Br J Pharmacol (1997) 121: 353-60 [PMID:9179373]
ChEMBL Binding affinity against Q89D human adenosine A2A receptor expressed in CHO cells using [3H]- ZM-241385 B 9.46 pKi 0.35 nM Ki J Med Chem (2003) 46: 4847-4859 [PMID:14584936]
ChEMBL Binding affinity for HA-tagged wild type human Adenosine A2A receptor (WT) using [3H]CGS-21680 as radioligand expressed in COS-7 cells B 9.85 pKi 0.14 nM Ki J Med Chem (1997) 40: 2588-2595 [PMID:9258366]
ChEMBL Inhibition of 1 uM NECA-stimulated cyclic AMP levels in human platelets F 7.92 pIC50 12 nM IC50 J Med Chem (1998) 41: 2126-2133 [PMID:9622554]
A2A receptor/Adenosine A2a receptor in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL302] [GtoPdb: 19] [UniProtKB: P30543]
ChEMBL Displacement [3H]-CGS-21,680 from Adenosine A2A receptor in rat striatal membrane. B 5.48 pKi 3300 nM Ki J Med Chem (1996) 39: 398-406 [PMID:8558508]
ChEMBL Displacement of [3H]ZM-241385 binding in adenosine A2A receptor of rat striatal membrane B 8.48 pKi 3.3 nM Ki J Med Chem (2001) 44: 749-762 [PMID:11262085]
ChEMBL Binding affinity was determined in radioligand binding assay at rat striatal Adenosine A2A receptor vs [3H]-CGS- 21680 B 8.48 pKi 3.3 nM Ki J Med Chem (1998) 41: 2835-2845 [PMID:9667972]
ChEMBL Inhibition of [3H]-CGS- 21680 binding to Adenosine A2A receptor in rat striatal homogenates. B 8.92 pKi 1.2 nM Ki J Med Chem (1996) 39: 1164-1171 [PMID:8676354]
ChEMBL Displacement of [3H]-CGS- from Adenosine A2a receptor of rat striatal homogenate B 8.92 pKi 1.2 nM Ki Bioorg Med Chem Lett (1994) 4: 2539-2544
ChEMBL Displacement of [3H]-CGS- 21680 from rat striatal membranes Adenosine A2A receptor. Parenthesis indicate 95% confidence limits. B 9.02 pKi 0.95 nM Ki J Med Chem (1998) 41: 2126-2133 [PMID:9622554]
ChEMBL Inhibition of rat recombinant adenosine receptor A2a B 9.4 pKi 0.4 nM Ki J Med Chem (2014) 57: 3623-3650 [PMID:24164628]
ChEMBL Binding affinity for Adenosine A2A receptor from rat striatal membranes using [3H]-CGH 21680 B 8.48 pIC50 3.3 nM IC50 J Med Chem (1996) 39: 4142-4148 [PMID:8863790]
A2B receptor/Adenosine A2b receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL255] [GtoPdb: 20] [UniProtKB: P29275]
ChEMBL pA2 value at human Adenosine A2B receptor from Schild plots with slopes approaching unity B 8 pKd 10 nM Kd J Med Chem (1998) 41: 2835-2845 [PMID:9667972]
ChEMBL Inhibition of human recombinant adenosine receptor A2b B 7.36 pKi 44 nM Ki J Med Chem (2014) 57: 3623-3650 [PMID:24164628]
ChEMBL Displacement of [3H]MRS-1754 from human recombinant adenosine A2B receptor expressed in HEK293 cells B 7.47 pKi 34.2 nM Ki J Med Chem (2009) 52: 3994-4006 [PMID:19569717]
ChEMBL Displacement of [3H]PSB-603 from human recombinant adenosine A2B receptor expressed in CHO cells B 7.52 pKi 30 nM Ki J Med Chem (2009) 52: 3994-4006 [PMID:19569717]
ChEMBL Displacement of [3H]DPCPX from Adenosine A2b receptor expressed in CHO cells; range 18-29 B 7.64 pKi 23 nM Ki J Med Chem (2000) 43: 4768-4780 [PMID:11123985]
ChEMBL Displacement of [125I]ZM-241385 from human recombinant adenosine A2B receptor expressed in HEK293 cells B 7.79 pKi 16.4 nM Ki J Med Chem (2009) 52: 3994-4006 [PMID:19569717]
ChEMBL Displacement of [3H]MRE-2029F20 from human recombinant adenosine A2B receptor expressed in HEK293 cells B 8.01 pKi 9.8 nM Ki J Med Chem (2009) 52: 3994-4006 [PMID:19569717]
GtoPdb - - 8.1 pKi - - - Naunyn Schmiedebergs Arch Pharmacol (1998) 357: 1-9 [PMID:9459566];
Naunyn Schmiedebergs Arch Pharmacol (1999) 359: 7-10 [PMID:9933143];
Biochem Pharmacol (2001) 61: 657-63 [PMID:11266650];
Biochem Pharmacol (2004) 68: 305-12 [PMID:15194002];
Drug Des Discov (1999) 16: 217-26 [PMID:10624567];
J Pharmacol Exp Ther (2009) 329: 2-13 [PMID:19141710]
ChEMBL Inhibition of 50 uM 5`-(N-ethylcarboxamido)adenosine induced cAMP production in CHO cell line expressing human Adenosine A2B receptor B 5.92 pIC50 1200 nM IC50 J Med Chem (1998) 41: 2835-2845 [PMID:9667972]
ChEMBL Displacement of PSB-12105 from recombinant human adenosine A2B receptor expressed in CHO cell membranes preincubated for 30 mins followed by PSB-12105 addition measured after 20 mins by flow cytometric method B 7.22 pIC50 60.7 nM IC50 J Med Chem (2018) 61: 4301-4316 [PMID:29681156]
GtoPdb - - 7.8 pA2 - - - Br J Pharmacol (1996) 119: 1286-90 [PMID:8937736]
A2B receptor in Mouse [GtoPdb: 20] [UniProtKB: Q60614]
GtoPdb - - 8.04 pKi 9.07 nM Ki J Pharmacol Exp Ther (2009) 329: 2-13 [PMID:19141710]
A3 receptor/Adenosine A3 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL256] [GtoPdb: 21] [UniProtKB: P0DMS8]
ChEMBL Displacement of [3H]MRE3008-F20 from human adenosine A3 receptor expressed in CHO cells after 120 mins B 4.07 pKi 84918.05 nM Ki Bioorg Med Chem Lett (2011) 21: 818-823 [PMID:21163647]
ChEMBL Binding affinity at Mutant (H272E) human adenosine A3 receptor expressed in COS-7 cells B 5.49 pKi 3260 nM Ki J Med Chem (2001) 44: 4125-4136 [PMID:11708915]
ChEMBL Binding affinity at wild-type Adenosine A3 receptor expressed in COS-7 cells B 6.6 pKi 253 nM Ki J Med Chem (2001) 44: 4125-4136 [PMID:11708915]
ChEMBL Binding affinity by its ability to displace [125I]AB-MECA from human adenosine A3 receptor expressed in HEK 293 cells B 6.84 pKi 143 nM Ki J Med Chem (2000) 43: 2227-2238 [PMID:10841801]
ChEMBL Displacement of specific [125I]AB-MECA binding at human adenosine A3 receptor expressed in HEK 293 cells. B 6.84 pKi 143 nM Ki J Med Chem (1998) 41: 3987-3993 [PMID:9767636]
ChEMBL Displacement of [125I]AB-MECA from human adenosine A3 receptor expressed in HEK 293 cells B 6.85 pKi 140 nM Ki J Med Chem (2001) 44: 749-762 [PMID:11262085]
ChEMBL Inhibition of human recombinant adenosine A3 receptor B 7.02 pKi 95 nM Ki J Med Chem (2014) 57: 3623-3650 [PMID:24164628]
ChEMBL Displacement of [3H]MRE 3008F20 from human adenosine A3 receptor expressed in CHO cells B 7.07 pKi 85 nM Ki J Med Chem (2006) 49: 4085-4097 [PMID:16821770]
ChEMBL Displacement of [3H]MRE3008-F20 from human adenosine A3 receptor expressed in CHO cells; range 76-95 B 7.07 pKi 85 nM Ki J Med Chem (2000) 43: 4768-4780 [PMID:11123985]
ChEMBL Binding affinity for human adenosine A3 receptor B 7.07 pKi 85 nM Ki J Med Chem (2005) 48: 152-162 [PMID:15634009]
ChEMBL Displacement of [125I]I-AB-MECA from human adenosine A3 receptor expressed in CHO cells after 90 mins by gamma counting analysis B 7.46 pKi 35 nM Ki Bioorg Med Chem Lett (2013) 23: 26-36 [PMID:23200243]
ChEMBL Competitive binding affinity to human adenosine A3 receptor expressed in CHO cells after 90 mins by flow cytometric analysis in presence of MRS5449 B 7.79 pKi 16.1 nM Ki Bioorg Med Chem Lett (2013) 23: 26-36 [PMID:23200243]
ChEMBL Displacement of [125I]AB-MECA from human Adenosine A3 receptor expressed in HEK293 cells B 7.85 pKi 14 nM Ki J Med Chem (1998) 41: 2126-2133 [PMID:9622554]
ChEMBL Binding affinity at cloned human adenosine A3 receptor expressed in HEK293 cells was determined using [125I]AB-MECA as radioligand B 7.86 pKi 13.8 nM Ki J Med Chem (1998) 41: 2835-2845 [PMID:9667972]
ChEMBL Antagonist activity at human adenosine A3 receptor F 7.86 pKi 13.8 nM Ki Bioorg Med Chem Lett (2011) 21: 2898-2905 [PMID:21511471]
ChEMBL Displacement of [125I]AB-MECA from human adenosine A3 receptor expressed in HEK 293 cells B 7.86 pKi 13.8 nM Ki J Med Chem (1998) 41: 3987-3993 [PMID:9767636]
ChEMBL In vitro binding affinity at human Adenosine A3 receptor from HEK293 cells by [125I]AB-MECA displacement. B 7.86 pKi 13.8 nM Ki J Med Chem (1996) 39: 4142-4148 [PMID:8863790]
GtoPdb - - 7.9 pKi - - - Naunyn Schmiedebergs Arch Pharmacol (1998) 357: 1-9 [PMID:9459566];
Naunyn Schmiedebergs Arch Pharmacol (1999) 359: 7-10 [PMID:9933143];
Mol Pharmacol (2000) 57: 968-75 [PMID:10779381];
J Med Chem (1996) 39: 4142-8 [PMID:8863790]
ChEMBL Displacement of [125I]AB-MECA from human adenosine A3 receptor expressed in CHO cells B 8.1 pKi 7.9 nM Ki J Med Chem (1998) 41: 3987-3993 [PMID:9767636]
ChEMBL Inhibition of cAMP accumulation in CHO cells expressing human adenosine A3 receptor F 6.39 pIC50 406 nM IC50 J Med Chem (2000) 43: 4768-4780 [PMID:11123985]
A3 receptor/Adenosine A3 receptor in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3360] [GtoPdb: 21] [UniProtKB: P28647]
ChEMBL Binding affinity for Adenosine A3 receptor from rat striatal membranes B 4 pKi 100000 nM Ki J Med Chem (1996) 39: 4142-4148 [PMID:8863790]
casein kinase 1 alpha 1/Casein kinase I alpha in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2793] [GtoPdb: 1995] [UniProtKB: P48729]
ChEMBL Inhibition of CK1alpha (unknown origin) B 6.09 pIC50 820 nM IC50 J Med Chem (2022) 65: 15263-15281 [PMID:36346705]
casein kinase 1 delta/Casein kinase I delta in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2828] [GtoPdb: 1997] [UniProtKB: P48730]
ChEMBL Inhibition of CK1delta (unknown origin) B 6.62 pIC50 240 nM IC50 J Med Chem (2022) 65: 15263-15281 [PMID:36346705]
casein kinase 1 epsilon/Casein kinase I epsilon in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4937] [GtoPdb: 1998] [UniProtKB: P49674]
ChEMBL Inhibition of CK1epsilon (unknown origin) B 6.31 pIC50 490 nM IC50 J Med Chem (2022) 65: 15263-15281 [PMID:36346705]
protein kinase, DNA-activated, catalytic subunit/DNA-dependent protein kinase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3142] [GtoPdb: 2800] [UniProtKB: P78527]
ChEMBL Inhibition of DNA-PK (unknown origin) B 6.85 pIC50 140 nM IC50 J Med Chem (2022) 65: 15263-15281 [PMID:36346705]
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha/PI3-kinase p110-alpha subunit in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4005] [GtoPdb: 2153] [UniProtKB: P42336]
ChEMBL Inhibition of PI3Kalpha (unknown origin) B 5.89 pIC50 1280 nM IC50 J Med Chem (2022) 65: 15263-15281 [PMID:36346705]
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta/PI3-kinase p110-beta subunit in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3145] [GtoPdb: 2154] [UniProtKB: P42338]
ChEMBL Inhibition of PI3Kbeta (unknown origin) B 5.07 pIC50 8480 nM IC50 J Med Chem (2022) 65: 15263-15281 [PMID:36346705]
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta/PI3-kinase p110-delta subunit in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3130] [GtoPdb: 2155] [UniProtKB: O00329]
ChEMBL Inhibition of PI3Kdelta (unknown origin) B 6.01 pIC50 970 nM IC50 J Med Chem (2022) 65: 15263-15281 [PMID:36346705]
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma/PI3-kinase p110-gamma subunit in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3267] [GtoPdb: 2156] [UniProtKB: P48736]
ChEMBL Inhibition of PI3Kgamma (unknown origin) B 6.96 pIC50 110 nM IC50 J Med Chem (2022) 65: 15263-15281 [PMID:36346705]
Plasmodium falciparum (target type: ORGANISM) [ChEMBL: CHEMBL364]
ChEMBL Antiplasmodial activity against Plasmodium falciparum GB4 after 72 hrs by SYBR green assay F 4.9 pIC50 12589.25 nM IC50 Nat Chem Biol (2009) 5: 765-771 [PMID:19734910]
ChEMBL Antiplasmodial activity against Plasmodium falciparum W2 after 72 hrs by SYBR green assay F 5 pIC50 10000 nM IC50 Nat Chem Biol (2009) 5: 765-771 [PMID:19734910]
ChEMBL Antiplasmodial activity against Plasmodium falciparum D10 after 72 hrs by SYBR green assay F 5.1 pIC50 7943.28 nM IC50 Nat Chem Biol (2009) 5: 765-771 [PMID:19734910]
ChEMBL Antiplasmodial activity against Plasmodium falciparum 7G8 after 72 hrs by SYBR green assay F 5.3 pIC50 5011.87 nM IC50 Nat Chem Biol (2009) 5: 765-771 [PMID:19734910]

ChEMBL data shown on this page come from version 34:

Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]